Biotech SF: Regeneron

Showing posts with label Regeneron. Show all posts

Thursday, April 28, 2011

Eye disease patients may want to see more green

As details started leaking out Wednesday from a much-anticipated head-to-head trial of two Genentech Inc. drugs in a potentially blinding eye disease, the folks at Regeneron Pharmaceuticals Inc. were wondering what it all means.That could be decided by patients with age-related macular degeneration who may want to see more of one thing: green in their wallets.

Subscribe to: Comments (Atom)

Some of my favorite stories.

• "The fight of his life" (2007)

Last year Mike Homer helped raise the money for 2,000 medical research computers. Now researchers are using that equipment in an attempt to save his life.

• "For reporter, CJD is more than a story" (2007)

Seven years ago -- nearly to the day -- my mother died of Creutzfeld-Jakob Disease.

• "A son's YouTube plea for Avastin" (2010)

Josh Turnage is your typical teenager, trying to discover what he wants to do in college and with his life. But a 7-minute, 41-second YouTube video he produced about his mother's fight with breast cancer may thrust him into a debate between drug makers and the agency that regulates them.

• "New device could knock out old dialysis technology" (2011)

Shuvo Roy has all the makings for the world's first implantable artificial kidney, thanks to nanotechnology and a web of nationwide collaborations.

All he needs now is $20 million.